Back
Enanta Pharmaceuticals Stock Price Chart
Sponsored
ENTA
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
26
ENTA
Enanta Pharmaceuticals
Last Price:
11.29
Seasonality Move:
3.99%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing slight buying pressure.
Enanta Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.76 | Sell |
20-day SMA: | 12.22 | Sell |
50-day SMA: | 13.25 | Sell |
200-day SMA: | 12.99 | Sell |
8-day EMA: | 11.64 | Sell |
20-day EMA: | 12.07 | Sell |
50-day EMA: | 12.68 | Sell |
200-day EMA: | 14.27 | Sell |
Enanta Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 36.07 | Sell |
Chaikin Money Flow: | 3002 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.68 - 12.88) | Sell |
Bollinger Bands (100): | (11.89 - 14.27) | Sell |
Enanta Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Enanta Pharmaceuticals Stock
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 11.28 while ENTA 8-day simple moving average is 11.76, which is a Sell signal.
- The stock price of ENTA is 11.28 while Enanta Pharmaceuticals 20-day SMA is 12.22, which makes it a Sell.
- Enanta Pharmaceuticals 50-day simple moving average is 13.25 while ENTA share price is 11.28, making it a Sell technically.
- ENTA stock price is 11.28 and Enanta Pharmaceuticals 200-day simple moving average is 12.99, creating a Sell signal.
ENTA Technical Analysis vs Fundamental Analysis
Sell
26
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals a Buy or a Sell?
-
Enanta Pharmaceuticals stock is rated a Sell
The current Enanta Pharmaceuticals [ENTA] share price is $11.28. The Score for ENTA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Enanta Pharmaceuticals Stock Info
Market Cap:
239.01M
Price in USD:
11.28
Share Volume:
195.14K
Enanta Pharmaceuticals 52-Week Range
52-Week High:
17.80
52-Week Low:
8.08
Sell
26
Enanta Pharmaceuticals (ENTA)
is a Sell
Enanta Pharmaceuticals Share Price Forecast
-
What is the Enanta Pharmaceuticals stock price today?
The Enanta Pharmaceuticals stock price is 11.28 USD today. -
Will ENTA stock go up or go down?
Enanta Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Enanta Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enanta Pharmaceuticals is overvalued.
Is Enanta Pharmaceuticals Stock a Buy?
- Enanta Pharmaceuticals share price is 11.28 while ENTA 8-day exponential moving average is 11.64, which is a Sell signal.
- The stock price of ENTA is 11.28 while Enanta Pharmaceuticals 20-day EMA is 12.07, which makes it a Sell.
- Enanta Pharmaceuticals 50-day exponential moving average is 12.68 while ENTA share price is 11.28, making it a Sell technically.
- ENTA stock price is 11.28 and Enanta Pharmaceuticals 200-day simple moving average is 14.27, creating a Sell signal.
Fundamental Analysis of Enanta Pharmaceuticals
Is Enanta Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.25 per share, an increase this year of $2.01 per share, and an increase next year of $0.23 per share.
Technical Analysis of Enanta Pharmaceuticals
Should I short Enanta Pharmaceuticals stock?
- ENTA Moving Average Covergence Divergence (MACD) indicator is -0.44, suggesting Enanta Pharmaceuticals is a Sell
- Enanta Pharmaceuticals Relative Strength Index (RSI) is 36.07, which suggest Enanta Pharmaceuticals is oversold
- The Bollinger Bands (25) for Enanta Pharmaceuticals is (11.68 - 12.88), which suggest Enanta Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Enanta Pharmaceuticals is (11.89 - 14.27), which suggest Enanta Pharmaceuticals is a Sell
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.